UGT1A1 and Decreased total neutrophil count: Patients who are homozygous for UGT1A1*28 have less capacity to eliminate SN38, and many studies have reported a significant increase risk of grade 3-4 neutropenia and/or diarrhea in those patients treated by irinotecan for metastatic colorectal cancer.